Schubert & Co’s Braskem BAK Stock Holding History

Schubert & Co’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10	Closed	-$92	–	1672
2022 Q4	$92	Sell	10 -20	-67%	-$222	﹤0.01%	1584
2022 Q3	$0	Buy	30 +15	+100%	+$187	﹤0.01%	1376
2022 Q2	$0	Buy	+15	New	+$257	﹤0.01%	1437

Other funds holding BAK

NIG

NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verdad Advisers Boston, Massachusetts $88.8M AUM

Schubert & Co's BAK Position: Q1 2023 in Review

Schubert & Co sold out of Braskem (BAK) in Q1 2023, closing a stake of 10 shares — an estimated $92 sold.

Schubert & Co first reported a position in BAK in Q2 2022 and held it in 3 quarters. The position peaked at $92 in Q4 2022. 53 funds tracked by Wall St. Rank hold BAK as of Q1 2023.

Schubert & Co reported no remaining Braskem position as of Q1 2023 after selling out during the quarter.
Schubert & Co sold 10 Braskem shares in Q1 2023, an estimated $92.
Schubert & Co first reported a position in Braskem in Q2 2022 and held it in 3 quarters.
Schubert & Co's Braskem position peaked at $92 in Q4 2022.
53 funds tracked by Wall St. Rank held Braskem as of Q1 2023.

Based on Schubert & Co's 13F filing for Q1 2023, filed 2 May 2023.